TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: PPT value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS at stairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower extremities muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discounting future rewards
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip circumference (HC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Index of Mortality 2 score
Endpoint domain: Mortality/survival
Primary endpoint: All-cause death at 10 years
Endpoint domain: Mortality/survival
Primary endpoint: incidence of type 2 diabetes (T2D)
Endpoint domain: Adverse events/effects
Primary endpoint: clearance of treated lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mean decrease in cumulative disease area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Visual quality improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scotopic pupil size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of glare or halos
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Median time to closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Filled volume ratio (Vf, %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high psychotic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high anxio-depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevated substance abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: genetic resistance determinants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: reduction in negative mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in response times of the anti-cue reaction time test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: daily emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: successful epidural access
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Global Health Status (GHS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of work-loss event
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cumulative added productivity value
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Self-directed learning scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Iron folic acid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fasting blood glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Selection of steak burrito as most damaging to health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived message effectiveness ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: STN levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: recurrent dislocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved patient outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in CAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Disease-Free Remission (DFR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Disease-Free Remission (SDFR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Connectivity of the lateral prefrontal cortex with thalamus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Immediate disappearance of varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CWRET time under hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean distance control at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myopic shift from baseline to 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF‐α gene promoter methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: days lived at home
Endpoint domain: Mortality/survival
Primary endpoint: Rate of hearing loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with audiology services
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Waiting times for audiology services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monitor compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of middle ear effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviation of chemotherapy-related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Mean VPI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BOP%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change in LDL cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: enhanced regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AGE episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived discomfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in deoxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support for infertility policies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: first MTP joint maximum dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ankle joint maximum plantarflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knee joint maximum flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Achilles tendon dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth color appearance dissatisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical function improvement (CM-PPT score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function improvement (MoCA score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatine-normalized urine maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state area under the concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Relatox compared to Botox
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of Relatox
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac function improvement (LVEF, LVESVI, WMSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence rates of acute myocardial infarction and related events
Endpoint domain: Adverse events/effects
Primary endpoint: Insulin sensitivity measured by HOMA-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of menses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progestin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Menstrual abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: serum C-terminal telopeptide of type I collagen (CTX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone health outcomes
Primary endpoint: urine titratable acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: urine pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Moral component of the Thought Action Fusion
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intrusiveness of the aggressive impulse
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Success rate of RLV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HCV-RNA level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum KIM-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical response with amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response in histopathological evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RASS-Agitation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Terminal hair count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average endometriotic implant size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of fever attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet Recovery Rate (PRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: POD1 pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative QOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 30-, 60-, and 90-day mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: Mean audiometric change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SaO2 parameter improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PCI-related myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in interleukin-6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-sensitivity C-reactive protein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDR bacterial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Viral shedding of infectious type 2 virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Depressive symptomatology improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Symptom improvement
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Grade >2 GI or GU toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: articulatory oral motor skill for /ta/
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in population mental health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: step-goal achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate at implant level
Endpoint domain: Mortality/survival
Primary endpoint: %Time pH ≥4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CUD symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-rated insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Incidence of CUD
Endpoint domain: Adverse events/effects
Primary endpoint: Pain level during endorectal ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of VRE-HAIs
Endpoint domain: Adverse events/effects
Primary endpoint: Radiation exposure of the patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of labour inductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rates of caesarean sections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: KTS (Kinematic Task Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain VAS scores during activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fentanyl consumption at 12 and 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at rest and upon movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Formation of granulation tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: proportion of neonates who received PPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow in the gastric antrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Financial toxicity related to acute respiratory distress syndrome hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Incidence of POAF at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Medication adherence for DPP-4 inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of hyperlipidemia drugs filled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hypermetropia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rate of change in ALSFRS-R score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: locoregional progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: incidence of grade 3+ radiotherapy pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Trabecular microstructure indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical vBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral blood oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall antibiotic use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intravenous levofloxacin use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ratio of oral to intravenous DOT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 4β‐OHC/Chol ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total score reduction of the PHQ-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total score reduction of the MADRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to MUS revision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of haemolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Extracellular potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean A1C decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial glucose (PPG) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of therapy sessions completed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dispensing rate of ARI-related antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in knowledge of relevant benefit-harm evidence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: KDIGO worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in total vessel volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in angiographic stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accurate identification of severe irritability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation from boundary presentations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep problems reported by leaders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leaders engaging in sleep leadership behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Unit members sleeping at least 7 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events of grade ≥ 3 severity
Endpoint domain: Adverse events/effects
Primary endpoint: overall quality of sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: total sleep duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative sleep disturbances
Endpoint domain: Adverse events/effects
Primary endpoint: proportion of patients with complete resolution of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: femur BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary DPD/Cr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait and postural disorders management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early death or severe neurologic injury
Endpoint domain: Mortality/survival
Primary endpoint: early death or spontaneous intestinal perforation
Endpoint domain: Mortality/survival
Primary endpoint: Hair TFV levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Viremia frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Lateral stability speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior stability speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception of susceptibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perception of severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perception scores of barriers to avoid SHS exposure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum levels of NE and BDNF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of placental insufficiency complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clinical reasoning questions performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in peak urinary flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hemoglobin levels in the target range of 10-12 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Numerical rating scale (NRS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: empathetic communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patient satisfaction survey ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of tumor distance measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in indices of appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in afternoon blood glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increase in satiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes